Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device
NCT ID: NCT02445313
Last Updated: 2019-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2015-06-30
2019-02-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Latest Version of NidekRS3000Adv
NCT03318705
Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
NCT02941263
Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)
NCT02395757
Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study
NCT05963646
Image Biomarkers for Progression of AMD
NCT04537143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Normal, healthy participants
Nidek MP-3
Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD
AMD
Age-related Macular Degeneration participants
Nidek MP-3
Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nidek MP-3
Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Participants who are unable to maintain retinal fixation on a specified target
3. Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place
4. Patients with media opacity which preclude high quality imaging will be excluded.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Doheny Image Reading Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Srinivas Sadda
Role: PRINCIPAL_INVESTIGATOR
Doheny Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Doheny Eye Centers UCLA
Pasadena, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDEKMP3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.